Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neublastin challenge study in healthy adults and episodic migraine patients
NL-OMON49543Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of artemin in migraine (4 arms), sponsored by Centre for Human Drug Research. Started Aug 2019; status: completed.
02
Drugs
artemin
03
Conditions
migraine
Beyond the preview
Go deeper on NL-OMON49543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49543.